i10e
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Laboratoire français de Fractionnement et de BiotechnologiesPhase 3Dormant
B
59/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 44/ 100
- Competitive Position
- 89/ 100
Competitive context
16 Active assets in the Chronic Inflammatory Demyelinating Polyradiculoneuropathy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
HUMAN IMMUNOGLOBULINS National Center for Research Resources (NCRR) | Phase 3 | BB |
AMIFAMPRIDINE National Center for Research Resources (NCRR) | Phase 3 | BB |
Cytosin-Arabinosid Fred Hutchinson Cancer Center | Phase 2 | CCC |
ETOPOSIDE Fred Hutchinson Cancer Center | Phase 2 | CCC |
CARMUSTINE Fred Hutchinson Cancer Center | Phase 2 | CCC |
View all 18 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →